Latest filing published 07 Aug 2017 for NEUROONE MEDICAL TECHNOLOGIES Corp.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Amer Samad: trading record in brief
Amer Samad discloses dealings in NEUROONE MEDICAL TECHNOLOGIES Corp to SEC (Form 4). The record holds 2 filings, for trades running from 19 May 2017 to 20 July 2017.
Every open-market trade on record is a purchase: 1 purchase worth €451, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 7 August 2017 with a transaction in NEUROONE MEDICAL TECHNOLOGIES Corp. The last insider purchase was made public on 14 July 2017, 3,405 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amer Samad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500,000 shares0Common StockSEC:0001009448-17-000036:0
- 15,728 shares@ US$0.0319100.0% of flowCommon StockSEC:0001009448-17-000032:0Canonical exit: 17 Aug 2017 (T+90)
2 of 2 declarations
